The strange case of Joseph Moshe has resurfaced.
In August of 2009, Moshe was accused of making threats against the White House. He briefly made headlines during a stand-off with police in Los Angeles. During the confrontation, the Israeli scientist remarkably withstood five rounds of chemical agent tossed inside his car in the parking lot of the Federal Building in West Los Angeles.
It was later learned that Moshe had called into a radio talk show and said he wanted to supply evidence regarding tainted H1N1 swine flu vaccines being produced by Baxter BioPharma Solutions. Moshe claimed a Baxter lab in Ukraine was producing a bioweapon that would be passed off as a vaccine. He said the vaccine contained an adjuvant engineered to weaken the immune system. Replicated RNA from the virus, Moshe insisted, was responsible for the 1918 pandemic Spanish flu.
It was speculated Moshe worked for Israel’s Mossad.
In late October of 2009, Ukraine was hit by an especially aggressive and virulent form of hemorrhagic pneumonia. “The virus appears to be either a highly aggressive mutation of the globally-circulating H1N1 strain, or a combination of three different influenza strains now circulating in Ukraine,” Mike Adams wrote at the time.
“Moshe claimed that Baxter’s laboratory in the Ukraine out of all places was creating this biological weapon. All of this came out in the beginning of August, which is more than 2 months before the situation that is currently unfolding [in Ukraine]. For Moshe to correctly name the country where a new epidemic would be unleashed, requires either inside information, or an incredible coincidence as anyone with a basic knowledge of statistics can confirm for himself,”David Rothscum wrote on October 31.
The H1N1 flu “pandemic” turned out to be mostly government and media hype. It was later said the United Nations’ World Health Organization had connived with Baxter, GlaxoSmithKline, Novartis, and Sanofi-Aventis to create a pandemic scare in order to sell vaccines.
In January of this year, the WHO insisted it was not unduly influenced by drug companies to exaggerate the dangers of the H1N1 flu virus. The WHO subsequently appointed a committee to investigate the allegations but its credibility suffered a serious blow when it was learned Dr. John Mackenzie would be included in the investigation. Mackenzie has direct links with several vaccine and pharmaceutical companies and was influential in the WHO declaration of a level 6 pandemic in 2009.
At the time, some 200 million doses of H1N1 vaccine and funding of approximately $12 million were pledged to fight the virus.
In February of 2009, Bloombergreported that Baxter had accidentally contaminated samples with the bird flu virus. The contamination was discovered when ferrets at a lab in the Czech Republic died after being inoculated with vaccine made from the samples. The virus material was supposed to contain a seasonal flu virus and was contaminated after “human error,” according to Baxter.
Dan Even, writing for Haaretz, reported earlier this week that a report had linked the deadly Cryptococcus gatti fungus to labs in the United States and the Nes Tziona Biological Institute in Israel. “The report also linked an Israeli American scientist, Dr. Joseph Moshe, to the spread of the fungus,” writes Even.
An outbreak of the fungus killed six people in Oregon and was predicted to move into northern California and possibly farther, according to experts. “No one knows how the species got to North America or how the fungus can thrive in a temperate region,” notes Christine Dell’Amoreof National Geographic News. Cryptococcus gattii is an airborne fungus native to tropical and subtropical regions, including Papua New Guinea, Australia, and parts of South America.
However, much like the H1N1 virus, the threat posed by the “killer” fungus appears to be little more than corporate media sensationalism.
“At its peak, we were seeing about 36 cases per million per year, so that is a very small number,” Christina Hull, an assistant professor of medical microbiology and immunology and of biomolecular chemistry at the University of Wisconsin School of Medicine and Public Health in Madison, told Bloomberg Businessweek on April 30.
Joseph Moshe is currently scheduled for a court hearing on his mental status on August 24, 2010, in California.